HK1130186A1 - Phospholipid analogue for the in vivo diagnosis of cancers - Google Patents
Phospholipid analogue for the in vivo diagnosis of cancersInfo
- Publication number
- HK1130186A1 HK1130186A1 HK09109089.4A HK09109089A HK1130186A1 HK 1130186 A1 HK1130186 A1 HK 1130186A1 HK 09109089 A HK09109089 A HK 09109089A HK 1130186 A1 HK1130186 A1 HK 1130186A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancers
- vivo diagnosis
- phospholipid analogue
- phospholipid
- analogue
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 238000003745 diagnosis Methods 0.000 title 1
- 238000001727 in vivo Methods 0.000 title 1
- 150000003904 phospholipids Chemical class 0.000 title 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- -1 phospholipid ether analogs Chemical class 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0408—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52116604P | 2004-03-02 | 2004-03-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1130186A1 true HK1130186A1 (en) | 2009-12-24 |
Family
ID=34919310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK09109089.4A HK1130186A1 (en) | 2004-03-02 | 2009-09-30 | Phospholipid analogue for the in vivo diagnosis of cancers |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US8535641B2 (ja) |
| EP (3) | EP2044960B1 (ja) |
| JP (7) | JP2007528374A (ja) |
| KR (1) | KR20070015518A (ja) |
| CN (1) | CN1929869B (ja) |
| AT (1) | ATE437657T1 (ja) |
| AU (1) | AU2005219412A1 (ja) |
| BR (1) | BRPI0508425A (ja) |
| CA (1) | CA2557698A1 (ja) |
| DE (1) | DE602005015687D1 (ja) |
| DK (1) | DK1729824T3 (ja) |
| ES (3) | ES2430065T3 (ja) |
| HK (1) | HK1130186A1 (ja) |
| IL (1) | IL177645A0 (ja) |
| MX (1) | MXPA06009681A (ja) |
| WO (1) | WO2005084716A2 (ja) |
| ZA (1) | ZA200607042B (ja) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2044960B1 (en) * | 2004-03-02 | 2013-11-20 | Cellectar, Inc. | Phospholipid analogue for the in vivo diagnosis of cancers |
| US8540968B2 (en) | 2004-03-02 | 2013-09-24 | Cellectar, Inc. | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
| AU2005269861A1 (en) * | 2004-07-08 | 2006-02-09 | Cellectar, Llc | Virtual colonoscopy with radiolabeled phospholipid ether analogs |
| EP1833514A2 (en) * | 2004-12-20 | 2007-09-19 | Cellectar, Llc | Phospholipid ether analogs for detecting and treating cancer |
| US20080075660A1 (en) * | 2006-08-15 | 2008-03-27 | Cellectar, Llc | Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
| US7893286B2 (en) | 2007-06-01 | 2011-02-22 | Cellectar, Inc. | Method for the synthesis of phospholipid ethers |
| WO2008150439A1 (en) | 2007-06-01 | 2008-12-11 | Cellectar, Inc. | Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use |
| WO2010011844A1 (en) * | 2008-07-25 | 2010-01-28 | Tufts Medical Center | A system and method of clinical treatment planning of complex, monte carlo-based brachytherapy dose distributions |
| WO2010132428A1 (en) * | 2009-05-11 | 2010-11-18 | Cellectar, Inc. | Fluorescent phospholipid ether compounds, compositions, and methods of use |
| US8871181B2 (en) | 2009-05-11 | 2014-10-28 | Cellectar, Inc. | Fluorescent phospholipid ether compounds, compositions, and methods of use |
| US7811548B1 (en) | 2009-05-11 | 2010-10-12 | Cellectar, Inc. | Fluorescent phospholipid ether compounds and compositions |
| ES2799411T3 (es) * | 2009-06-12 | 2020-12-17 | Cellectar Inc | Compuestos alquilfosfolipídicos para el tratamiento de cáncer y obtención de imágenes y detección de células madre cancerosas |
| US10007961B2 (en) * | 2009-09-09 | 2018-06-26 | Wisconsin Alumni Research Foundation | Treatment planning system for radiopharmaceuticals |
| US20110064661A1 (en) * | 2009-09-11 | 2011-03-17 | Pinchuk Anatoly | Non-radioactive phospholipid compounds, compositions, and methods of use |
| PT3229810T (pt) | 2014-11-17 | 2020-08-27 | Cellectar Biosciences Inc | Análogos de éter fosfolipídico como veículos de medicamentos direcionados para o cancro |
| JP6883046B2 (ja) | 2015-11-06 | 2021-06-02 | ウイスコンシン アラムナイ リサーチ ファウンデーシヨンＷｉｓｃｏｎｓｉｎ Ａｌｕｍｎｉ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | 長寿命ガドリニウムに基づく腫瘍標的化イメージングおよび治療薬 |
| NZ749272A (en) * | 2016-06-14 | 2023-01-27 | Cellectar Biosciences Inc | Phospholipid ether analogs for the identification and isolation of circulating tumor cells |
| US11147823B2 (en) * | 2016-07-13 | 2021-10-19 | Wisconsin Alumni Research Foundation | Phospholipid ether analogs for imaging and targeted treatment of pediatric solid tumors |
| US11633506B2 (en) | 2016-07-18 | 2023-04-25 | Wisconsin Alumni Research Foundation | Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies |
| EP3484513B1 (en) * | 2016-07-18 | 2023-06-07 | Wisconsin Alumni Research Foundation | Radiohalogenated agents for combined cancer therapy |
| CA3031776C (en) * | 2016-07-25 | 2024-02-20 | Wisconsin Alumni Research Foundation | Targeted radiotherapy chelates for in situ immune modulated cancer vaccination |
| US20180022768A1 (en) * | 2016-07-25 | 2018-01-25 | Wisconsin Alumni Research Foundation | Radioactive phospholipid metal chelates for cancer imaging and therapy |
| EP3579870A4 (en) | 2017-02-07 | 2020-12-30 | Seattle Children's Hospital (DBA Seattle Children's Research Institute) | PHOSPHOLIPID ETHER (PLE) T CAR-LYMPHOCYTE TUMOR (CTCT) TARGETING AGENTS |
| JP7178355B2 (ja) | 2017-02-28 | 2022-11-25 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞療法のための組成物および方法 |
| KR20200088374A (ko) * | 2017-11-10 | 2020-07-22 | 위스콘신 얼럼나이 리서어치 화운데이션 | 면역요법에 대한 항-종양 면역 반응을 유도하기 위해 표적화된 방사선요법(trt)을 이용하는 방법 |
| US20190184040A1 (en) * | 2017-12-15 | 2019-06-20 | Wisconsin Alumni Research Foundation | Targeted Macrocyclic Agents for Dual Modality PET and MRI Imaging of Cancer |
| CA3089051A1 (en) | 2018-01-22 | 2019-07-25 | Endocyte, Inc. | Methods of use for car t cells |
| US20200354477A1 (en) * | 2018-02-06 | 2020-11-12 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors |
| WO2021072300A1 (en) * | 2019-10-10 | 2021-04-15 | Cellectar Biosciences, Inc. | Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5851526A (en) * | 1985-04-19 | 1998-12-22 | Ludwig Institute For Cancer Research | Methods of treating colon cancer utilizing tumor-specific antibodies |
| US4873075A (en) * | 1985-09-10 | 1989-10-10 | The University Of Michigan | Polyiodinated triglyceride analogs as radiologic agents |
| US4957729A (en) * | 1985-09-10 | 1990-09-18 | The University Of Michigan | Polyiodinated triglyceride analogs as radiologic agents |
| US5093042A (en) * | 1985-09-10 | 1992-03-03 | The University Of Michigan | Polyiodinated triglyceride analogs as radiologic agents |
| US4925649A (en) | 1987-06-12 | 1990-05-15 | The University Of Michigan | Radioiodinated diacylglycerol analogues and methods of use |
| US5087721A (en) * | 1987-10-23 | 1992-02-11 | The University Of Michigan | Radioiodinated phosphate esters |
| US5347030A (en) | 1987-10-23 | 1994-09-13 | The Board Of Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogues and methods of using same |
| US4965391A (en) | 1987-10-23 | 1990-10-23 | The University Of Michigan | Radioiodinated phospholipid ether analogues |
| US5041859A (en) * | 1988-10-04 | 1991-08-20 | Nikon Corporation | Automatic focusing detection device for cameras |
| US5274113A (en) | 1991-11-01 | 1993-12-28 | Molecular Probes, Inc. | Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates |
| US5369097A (en) | 1991-04-25 | 1994-11-29 | The University Of British Columbia | Phosphonates as anti-cancer agents |
| US5783170A (en) * | 1991-11-27 | 1998-07-21 | Diatide, Inc. | Peptide-metal chelate conjugates |
| US5626654A (en) | 1995-12-05 | 1997-05-06 | Xerox Corporation | Ink compositions containing liposomes |
| WO1998024480A1 (en) | 1996-12-04 | 1998-06-11 | The Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogs and methods of using the same |
| US6255519B1 (en) * | 1996-12-04 | 2001-07-03 | Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogs and methods of using the same |
| US6503478B2 (en) | 1999-01-13 | 2003-01-07 | Lightouch Medical, Inc. | Chemically specific imaging of tissue |
| CA2370081C (en) * | 1999-06-24 | 2014-06-03 | The University Of British Columbia | Lpl variant therapeutics |
| WO2002042462A2 (en) * | 2000-11-27 | 2002-05-30 | Praecis Pharmaceuticals Inc. | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| PT1404319E (pt) * | 2001-06-06 | 2006-08-31 | Brookhaven Science Ass Llc | Novas metaloporfirinas e suas utilizacoes como radiossensibilizadores para terapia de radiacao |
| US7220539B1 (en) | 2002-06-12 | 2007-05-22 | The Salk Institute For Biological Studies | Protein kinase B/Akt modulators and methods for the use thereof |
| KR101228124B1 (ko) * | 2002-06-14 | 2013-01-31 | 이뮤노메딕스, 인코오포레이티드 | 단클론 항체 ｐａｍ4 및 췌장암의 진단 및 치료를 위한이들의 용도 |
| CA2492878A1 (en) * | 2002-07-19 | 2004-01-29 | Ludwig Institute For Cancer Research | Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| EP1670946B1 (en) | 2003-09-19 | 2012-11-07 | bioTheranostics, Inc. | Predicting breast cancer treatment outcome |
| WO2005063774A1 (en) | 2003-12-22 | 2005-07-14 | Johns Hopkins University | Boronic acid aryl analogs |
| US8540968B2 (en) | 2004-03-02 | 2013-09-24 | Cellectar, Inc. | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
| US7632644B2 (en) | 2004-03-02 | 2009-12-15 | Cellectar, Inc. | Imaging and selective retention of phospholipid ether analogs |
| EP2044960B1 (en) | 2004-03-02 | 2013-11-20 | Cellectar, Inc. | Phospholipid analogue for the in vivo diagnosis of cancers |
| WO2005097158A1 (en) | 2004-03-29 | 2005-10-20 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Amphipathic glycopeptides |
| AU2005269861A1 (en) | 2004-07-08 | 2006-02-09 | Cellectar, Llc | Virtual colonoscopy with radiolabeled phospholipid ether analogs |
| US20060115426A1 (en) | 2004-08-11 | 2006-06-01 | Weichert Jamey P | Methods of detecting breast cancer, brain cancer, and pancreatic cancer |
| US7041859B1 (en) | 2004-09-09 | 2006-05-09 | University Of Tennessee Research Foundation | Method for halogenating or radiohalogenating a chemical compound |
| EP1833514A2 (en) * | 2004-12-20 | 2007-09-19 | Cellectar, Llc | Phospholipid ether analogs for detecting and treating cancer |
| US20080075660A1 (en) | 2006-08-15 | 2008-03-27 | Cellectar, Llc | Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
| WO2008150439A1 (en) * | 2007-06-01 | 2008-12-11 | Cellectar, Inc. | Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use |
| US7893286B2 (en) | 2007-06-01 | 2011-02-22 | Cellectar, Inc. | Method for the synthesis of phospholipid ethers |
| GB0819280D0 (en) | 2008-10-21 | 2008-11-26 | Gen Electric | Imgaing and radiotherapy methods |
| ES2799411T3 (es) | 2009-06-12 | 2020-12-17 | Cellectar Inc | Compuestos alquilfosfolipídicos para el tratamiento de cáncer y obtención de imágenes y detección de células madre cancerosas |
| US20110064661A1 (en) | 2009-09-11 | 2011-03-17 | Pinchuk Anatoly | Non-radioactive phospholipid compounds, compositions, and methods of use |
| US20110064660A1 (en) | 2009-09-11 | 2011-03-17 | Pinchuk Anatoly | Deuterated alkyl phospholipid compounds, compositions, and methods of use |
-
2005
- 2005-03-02 EP EP08010321.1A patent/EP2044960B1/en active Active
- 2005-03-02 DE DE602005015687T patent/DE602005015687D1/de active Active
- 2005-03-02 EP EP08020805.1A patent/EP2044961B1/en active Active
- 2005-03-02 EP EP05729873A patent/EP1729824B1/en active Active
- 2005-03-02 WO PCT/US2005/006681 patent/WO2005084716A2/en active Application Filing
- 2005-03-02 CA CA002557698A patent/CA2557698A1/en not_active Abandoned
- 2005-03-02 US US10/906,687 patent/US8535641B2/en active Active
- 2005-03-02 MX MXPA06009681A patent/MXPA06009681A/es active IP Right Grant
- 2005-03-02 AU AU2005219412A patent/AU2005219412A1/en not_active Abandoned
- 2005-03-02 ES ES08020805T patent/ES2430065T3/es active Active
- 2005-03-02 BR BRPI0508425-3A patent/BRPI0508425A/pt not_active Application Discontinuation
- 2005-03-02 AT AT05729873T patent/ATE437657T1/de not_active IP Right Cessation
- 2005-03-02 ES ES05729873T patent/ES2330951T3/es active Active
- 2005-03-02 KR KR1020067018488A patent/KR20070015518A/ko not_active Application Discontinuation
- 2005-03-02 ES ES08010321.1T patent/ES2440257T3/es active Active
- 2005-03-02 DK DK05729873T patent/DK1729824T3/da active
- 2005-03-02 CN CN2005800070569A patent/CN1929869B/zh active Active
- 2005-03-02 JP JP2007501917A patent/JP2007528374A/ja not_active Withdrawn
-
2006
- 2006-08-22 IL IL177645A patent/IL177645A0/en unknown
- 2006-08-23 ZA ZA200607042A patent/ZA200607042B/en unknown
-
2009
- 2009-09-30 HK HK09109089.4A patent/HK1130186A1/xx unknown
-
2012
- 2012-01-13 JP JP2012005213A patent/JP2012097113A/ja not_active Withdrawn
- 2012-10-24 JP JP2012234608A patent/JP2013040201A/ja active Pending
-
2013
- 2013-08-12 US US13/964,315 patent/US8877159B2/en active Active
-
2014
- 2014-07-18 JP JP2014147869A patent/JP6228080B2/ja active Active
- 2014-09-30 US US14/501,373 patent/US9550002B2/en active Active
-
2015
- 2015-01-05 JP JP2015000135A patent/JP6342818B2/ja active Active
-
2016
- 2016-07-08 JP JP2016135920A patent/JP6453818B2/ja active Active
-
2017
- 2017-05-31 JP JP2017108141A patent/JP2017173339A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1130186A1 (en) | Phospholipid analogue for the in vivo diagnosis of cancers | |
| IL187343A0 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| HUS1600049I1 (hu) | Bruton tirozinkináz inhibitorok | |
| ZA200702322B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| EP1937280A4 (en) | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND THERAPY OF BCL2 ASSOCIATED TUMORS | |
| ATE527552T1 (de) | Mr-darstellungsverfahren zur diskriminierung zwischen gesundem und tumorgewebe | |
| BRPI0607728A2 (pt) | complexo de lipoproteìna carregado reconstituìdo, composição farmacêutica, e, uso de um complexo de lipoproteìna carregado | |
| MX2009008430A (es) | Anticuerpos anti-robo4 y sus usos. | |
| EP2359864A3 (en) | Targeting Vector-Phospholipid Conjugates | |
| IL189104A (en) | Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders. | |
| IL178435A0 (en) | Beta-carbolines useful for treating inflammatory disease | |
| CY1115725T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων | |
| ZA200510282B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| DK1228770T3 (da) | Törret kontrastmiddel | |
| WO2009076388A3 (en) | Targeting vector-phospholipid conjugates | |
| AU2003237792A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| PT1492501E (pt) | Métodos de uso de corpos lamelares para propósitos terapêuticos | |
| EP1611151A4 (en) | STQ Peptides | |
| SI1606233T1 (sl) | Fosfolipidni estri klofarabina | |
| IL185653A (en) | Antibodies that call for the 1-kim salt region | |
| EP1797430A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER | |
| IL185900A0 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| NO20064232L (no) | Alfa.emitterende hydroksyapatittparikler | |
| ZA200604365B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| MXPA05008293A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. |